Since many clinical data support a pro-tumorigenic role of PTHrP by modulating proliferation, apoptosis and cell survival and acting as a negative regulator of tumor cell dormancy [37], we investigated in LALSCC the contribution of the expression pattern of PTHrP and PTH1R to tumor behavior and clinical outcome. This evidence concerns the gene PTH1R and neoplasm.